Hyperlipidemia after heart transplantation: Report of a 6-year experience, with treatment recommendations-Reference-Cited by-同舟云学术

Hyperlipidemia after heart transplantation: Report of a 6-year experience, with treatment recommendations

Published:1992-05 Issue:6 Volume:19 Page:1315-1321
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Ballantyne Christie M.,Radovancevic Branislav,Farmer John A.,Frazier O.Howard,Chandler Linda,Payton-Ross Charlotte,Cocanougher Beth,Jones Peter H.,Young James B.,Gotto Antonio M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference44 articles.

1. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults;The Expert Panel;Arch Intern Med,1988

2. Cardiac transplant atherosclerosis;Billingham;Transplant Proc,1987

3. Effects of cyclosporine therapy on plasma lipoprotein levels;Ballantyne;JAMA,1989

4. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative centrifuge;Friedewald;Clin Chem,1972

5. Hyperlipidemia following heart transplantation: natural history and intervention with mevinolin (lovastatin);Ballantyne;Transplant Proc,1987

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hurdles to Cardioprotection in the Critically Ill;International Journal of Molecular Sciences;2019-08-05

2. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association;Arteriosclerosis, Thrombosis, and Vascular Biology;2019-02

3. Hypercholesterolemia after conversion to sirolimus as primary immunosuppression and cardiac allograft vasculopathy in heart transplant recipients;The Journal of Heart and Lung Transplantation;2018-11

4. Early detection of cardiac allograft vasculopathy using highly automated 3-dimensional optical coherence tomography analysis;The Journal of Heart and Lung Transplantation;2018-08

5. Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients;ESC Heart Failure;2018-07-17